BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31994754)

  • 1. The application of ceragenins to orthopedic surgery and medicine.
    Dao A; Mills RJ; Kamble S; Savage PB; Little DG; Schindeler A
    J Orthop Res; 2020 Sep; 38(9):1883-1894. PubMed ID: 31994754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSA-90 reduces periprosthetic joint infection in a novel rat model challenged with local and systemic Staphylococcus aureus.
    Mills RJ; Boyling A; Cheng TL; Peacock L; Savage PB; Tägil M; Little DG; Schindeler A
    J Orthop Res; 2020 Sep; 38(9):2065-2073. PubMed ID: 32009241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of oral fleroxacin given once daily in patients with bone and joint infections.
    Putz PA
    Am J Med; 1993 Mar; 94(3A):177S-181S. PubMed ID: 8452177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Prosthetic Joint Infection.
    Tande AJ; Gomez-Urena EO; Berbari EF; Osmon DR
    Infect Dis Clin North Am; 2017 Jun; 31(2):237-252. PubMed ID: 28366224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental models of bone and prosthetic joint infections.
    Crémieux AC; Carbon C
    Clin Infect Dis; 1997 Dec; 25(6):1295-302. PubMed ID: 9431367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganisms.
    Bozkurt Guzel C; Oyardi O; B Savage P
    J Chemother; 2018; 30(6-8):332-337. PubMed ID: 30663553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
    BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
    Rao N; Hamilton CW
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):173-9. PubMed ID: 17574788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131.
    Chmielewska SJ; Skłodowski K; Piktel E; Suprewicz Ł; Fiedoruk K; Daniluk T; Wolak P; Savage PB; Bucki R
    Infect Drug Resist; 2020; 13():3277-3294. PubMed ID: 33061475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ceragenins and conventional antimicrobials on Candida albicans and Staphylococcus aureus mono and multispecies biofilms.
    Hacioglu M; Haciosmanoglu E; Birteksoz-Tan AS; Bozkurt-Guzel C; Savage PB
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114863. PubMed ID: 31471074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Characterization of Bone Binding Antibiotic-1 (BBA-1), a Novel Antimicrobial for Orthopedic Applications.
    Kamble S; Valtchev P; Dao A; Pelras T; Rogers MJ; Savage PB; Dehghani F; Schindeler A
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusidic acid in bone and joint infections.
    Atkins B; Gottlieb T
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S79-93. PubMed ID: 10528790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review.
    Telles JP; Cieslinski J; Tuon FF
    Braz J Infect Dis; 2019; 23(3):191-196. PubMed ID: 31207214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis.
    Ford CA; Cassat JE
    Expert Rev Anti Infect Ther; 2017 Sep; 15(9):851-860. PubMed ID: 28837368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthopaedic biofilm infections.
    Zimmerli W; Sendi P
    APMIS; 2017 Apr; 125(4):353-364. PubMed ID: 28407423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens.
    Saha S; Savage PB; Bal M
    J Appl Microbiol; 2008 Sep; 105(3):822-8. PubMed ID: 18452533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid in the treatment of implant-related chronic osteomyelitis.
    Vercillo M; Patzakis MJ; Holtom P; Zalavras CG
    Clin Orthop Relat Res; 2007 Aug; 461():40-3. PubMed ID: 17514011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues.
    Arciola CR; Visai L; Testoni F; Arciola S; Campoccia D; Speziale P; Montanaro L
    Int J Artif Organs; 2011 Sep; 34(9):771-80. PubMed ID: 22094556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm-based implant infections in orthopaedics.
    Arciola CR; Campoccia D; Ehrlich GD; Montanaro L
    Adv Exp Med Biol; 2015; 830():29-46. PubMed ID: 25366219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of linezolid in the treatment of orthopedic infections.
    Bassetti M; Righi E; Di Biagio A; Rosso R; Beltrame A; Bassetti D
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):343-52. PubMed ID: 15954851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.